LXRX
LEXICON PHARMACEUTICALS, INC. · Healthcare
Insider Buying
$723K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jun 4, 2026
DEBBANE RAYMOND
LEXICON PHARMACEUTICALS, INC. (LXRX) has 21 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 4, 2026.
Inside the rolling window, 1 insider at LEXICON PHARMACEUTICALS, INC. reported 7 open-market purchases totaling $723K and no open-market sales. The most active filer is Director DEBBANE RAYMOND with 7 filings. Insiders have net bought $723K over the trailing 6 months. The most recent open-market filing is a purchase of 2,000 shares by Director DEBBANE RAYMOND, dated Feb 25, 2026, worth $3K.
- Industry:Biotechnology
- CEO:Michael S. Exton
- Employees:81
- HQ:The Woodlands, TX, US
- IPO:2000-04-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 2,000 | $3K | Feb 27 | +49.0% | SEC ↗ | |
| Director | Purchase | 100,000 | $147K | Feb 25 | +46.0% | SEC ↗ | |
| Director | Purchase | 50,000 | $72K | Feb 23 | +45.0% | SEC ↗ | |
| Director | Purchase | 100,000 | $148K | Feb 23 | +45.0% | SEC ↗ | |
DEBBANE RAYMONDFirst filing | Director | Purchase | 57,952 | $76K | Feb 18 | +65.9% | SEC ↗ |
DEBBANE RAYMONDFirst filing | Director | Purchase | 76,857 | $101K | Feb 18 | +65.9% | SEC ↗ |
DEBBANE RAYMONDFirst filing | Director | Purchase | 133,688 | $176K | Feb 18 | +65.9% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does LXRX have?
LEXICON PHARMACEUTICALS, INC. (LXRX) has 21 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 4, 2026.
When was the most recent SEC Form 4 filing for LXRX?
The most recent Form 4 filing for LXRX on Tracefour is dated Jun 4, 2026.
Who is the most active insider at LXRX?
The most active SEC Form 4 filer at LXRX in the rolling window is Director DEBBANE RAYMOND, with 7 filings.
What is the net insider flow at LXRX over the last 6 months?
Over the trailing 180 days, insiders at LXRX have net bought $723K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LXRX in the current window?
Inside the rolling window, insiders at LXRX bought $723K and sold $0 based on SEC Form 4 filings.
Can I get alerts for LXRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at LEXICON PHARMACEUTICALS, INC. (LXRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
LEXICON PHARMACEUTICALS, INC. is in the Healthcare sector.